Fintech SPAC AIB Acquisition Seeks To Raise US$75 Million In IPO

Special purpose acquisition company AIB Acquisition Corporation (Nasdaq: AIBBU) went public on the Nasdaq Global Market today. The firm is looking to raise US$75.0 million through its initial public offering.

The offering consists of 7.5 million units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one right to receive 1/10 of a common share upon the completion of business combination.

The company units trade on the Nasdaq big board under the symbol “AIBBU”. Once the securities separate, the company shares and rights will trade under the ticker symbols “AIB” and “AIBBR”, respectively.

The offering, expected to close on January 21, 2022, is being managed by Maxim Group as the sole bookrunner. The company has granted the underwriter a 45-day over-allotment option to purchase additional 1.125 million company units at the same IPO price.

The blank-check company intends to focus on businesses in the fintech industry. The firm is backed by American International Bank whose CEO Eric Chen also leads the SPAC as the chief executive officer.


Information for this briefing was found via Edgar the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Power Metallic Pushes Deeper Into Saudi Arabia With Amaar Mining Tie-Up

Canada Confirms First Hantavirus Case Linked to MV Hondius Cruise Ship Outbreak

Related News

Fintech SPAC World Quantum Growth Acquisition Prices Downsized US$200 Million IPO

Blank check company World Quantum Growth Acquisition Corp. (NYSE: WQGA.U) went public yesterday on the...

Thursday, August 12, 2021, 04:37:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Coinbase: The IPO Deep Dive

Coinbase Global (NASDAQ: COIN) is one of the hottest deals coming to market in 2021...

Tuesday, April 13, 2021, 01:30:00 PM

Tampa Bay Rays Owner-Led SPAC Counter Press Acquisition Prices US$75 Million IPO

Special purpose acquisition company Counter Press Acquisition Corp. (Nasdaq: CPAQU) started trading publicly on the...

Thursday, February 10, 2022, 02:21:00 PM

HempFusion Files For US$17 Million Initial Public Offering

HempFusion Wellness, the CBD firm that caused much excitement last year when it conducted a...

Thursday, October 22, 2020, 10:32:49 AM